The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

MLA

G.W. van Pelt, et al. “The Value of Tumor-Stroma Ratio as Predictor of Pathologic Response after Neoadjuvant Chemoradiotherapy in Esophageal Cancer.” Clinical and Translational Radiation Oncology, vol. 20, no. 39–44, Jan. 2020, pp. 39–44. EBSCOhost, https://doi.org/10.1016/j.ctro.2019.11.003.

APA

G.W. van Pelt, J.A. Krol, I.M. Lips, F.P. Peters, D. van Klaveren, J.J. Boonstra, W.O. de Steur, R.A.E.M. Tollenaar, A. Farina Sarasqueta, W.E. Mesker, & M. Slingerland. (2020). The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer. Clinical and Translational Radiation Oncology, 20(39–44), 39–44. https://doi.org/10.1016/j.ctro.2019.11.003

Chicago

G.W. van Pelt, J.A. Krol, I.M. Lips, F.P. Peters, D. van Klaveren, J.J. Boonstra, W.O. de Steur, et al. 2020. “The Value of Tumor-Stroma Ratio as Predictor of Pathologic Response after Neoadjuvant Chemoradiotherapy in Esophageal Cancer.” Clinical and Translational Radiation Oncology 20 (39–44): 39–44. doi:10.1016/j.ctro.2019.11.003.